Bristol-Myers Squibb

Bristol-Myers Squibb Second Quarter Earnings Preview
Investopedia
Mon, 07/23/12 - 10:02 pm
earnings
Bristol-Myers Squibb
A Busy Week For Bio-Pharma Earnings, Drug Approvals
TheStreet.com
Mon, 07/23/12 - 09:15 am
drug approvals
earnings
Amylin
InterMune
Human Genome Sciences
GSK
Bristol-Myers Squibb
Questcor
BiogenIdec
Alexion
Regeneron
Eli Lilly
Amarin
Horizon Pharma
Celgene
Amgen
Gilead
Alkermes
United Therapeutics
Roche
Sanofi
Merck
AstraZeneca
Salix
Progenics Pharmaceuticals
Double Disappointment! Has This Pharma Lost Its Touch?
Motley Fool
Sun, 07/22/12 - 08:35 am
Bristol-Myers Squibb
Personalized Medicine Plus Diagnostics Equals Profits for Investors
Motley Fool
Sat, 07/21/12 - 11:58 am
Therascreen
Qiagen
Eli Lilly
Bristol-Myers Squibb
Agilent
Bristol-Myers Squibb Second Quarter Earnings Sneak Peek
Wall St Cheat Street
Sat, 07/21/12 - 11:50 am
Bristol-Myers Squibb
earnings
Plavix tops U.S. sales ranks, but not for long
Fierce Pharma
Thu, 07/19/12 - 03:31 pm
Plavix
Bristol-Myers Squibb
Pluristem Therapeutics' Answer To Big Pharma's Question: What Do We Do Now?
Seeking Alpha
Wed, 07/18/12 - 12:27 pm
Pluristem Therapeutics
Alkermes
AstraZeneca
Bristol-Myers Squibb
Isis Pharmaceuticals
Eli Lilly
Momenta
Merck
Pfizer
Sanofi
Spectrum Pharmaceuticals
Sanofi: Don't Ignore This Powerhouse
Seeking Alpha
Mon, 07/16/12 - 08:47 am
Sanofi
Merck
Pfizer
Bristol-Myers Squibb
Bayer
Bristol-Myers Squibb: Don't Miss This Attractive Entry Point
Seeking Alpha
Sun, 07/15/12 - 11:49 am
Bristol-Myers Squibb
Can These 3 Companies Take Down Gilead?
Motley Fool
Thu, 07/12/12 - 11:27 am
Gilead
HIV
ViiV Healthcare
Shionogi
Merck
Bristol-Myers Squibb
Top 20 biotech licensing deals in H1 2012
Fierce Biotech
Wed, 07/11/12 - 12:47 pm
Xenon
Virobay
Tolero Pharmaceuticals
Threshold Pharmaceuticals
Novartis
Merck KGaA
Merck
MannKind
licensing
Janssen
Isis Pharmaceuticals
Ironwood
Inhibrx Thrombogenics
GSK
Genmab
Genentech
Galapagos
Forma Therapeutics
Endocyte
Endo
Enanta
Celgene
Bristol-Myers Squibb
Boehringer Ingelheim
Bionomics
Biogen Idec
BioDelivery Sciences
AstraZeneca
Angiochem
AC Immune
Abbott Laboratories
LEO Pharma
Pfizer May Sink On New Drug Woes
Seeking Alpha
Tue, 07/10/12 - 11:15 am
Pfizer
Abbott Laboratories
Bristol-Myers Squibb
Shire
Watson Pharmaceuticals
Bristol-Myers starts tender offer for Amylin
Reuters
Tue, 07/10/12 - 11:14 am
tender offer
M&A
Amylin
Bristol-Myers Squibb
Amylin Deal Signals Diabetes Space is Hot
Motley Fool
Fri, 07/6/12 - 07:34 pm
diabetes
Amylin
M&A
Bristol-Myers Squibb
AstraZeneca
Bristol-Myers Gets U.S. Approval For Wider Erbitux Use
Bloomberg
Fri, 07/6/12 - 07:21 pm
Bristol-Myers Squibb
colorectal cancer
Eli Lilly
Erbitux
These 2 Big Pharma Stocks Will Leap By 2013 (BMY, PFE)
Seeking Alpha
Fri, 07/6/12 - 10:44 am
Abbott Laboratories
Amylin
Bristol-Myers Squibb
Novartis
Pfizer
Bristol-Myers Squibb: Buy Before Eliquis Entry In 2013
Seeking Alpha
Thu, 07/5/12 - 12:56 pm
Bristol-Myers Squibb
Eliquis
JNJ
Mylan
Pfizer
Dr Reddy's
Expert On The Amylin Purchase: 'I Hate This Deal'
Forbes
Tue, 07/3/12 - 01:07 pm
Amylin
Bristol-Myers Squibb
M&A
AstraZeneca
Melanoma Treatments Look To Benefit From Large Market
Seeking Alpha
Tue, 07/3/12 - 11:46 am
Amgen
Bristol-Myers Squibb
GSK
OncoSec
Vical
Today's Bio Pharma Buyout News And Watch List
Seeking Alpha
Tue, 07/3/12 - 11:38 am
Amylin
AstraZeneca
Obagi Medical Products
Eli Lilly
GSK
Bristol-Myers Squibb

Pages